Anxiety and Related Sleep Disorders - Morocco

Revenue in the Anxiety and Related Sleep Disorders market is projected to reach US$18.68m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.34%, resulting in a market volume of US$19.00m by 2029.
In global comparison, most revenue will be generated United States (US$3.21bn in 2024).
In relation to total population figures, per person revenues of US$7.35 are generated in 2024.

The Anxiety and Related Sleep Disorders market covers sales of three drug classes: anxiolytics, hypnotics, and sedatives. These classes contain different types of drugs, such as benzodiazepines, anticonvulsants, and antihistamines, that reduce anxiety and insomnia symptoms caused by anxiety. These medications mainly fall into the category of prescription drugs.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Pfizer, Bristol-Myers Squibb, GlaxoSmithKline PLC, Johnson & Johnson, and Merck & Co.

Pharmaceutical sales and consumption of anxiolytics
Pharmaceutical sales and consumption hypnotics and sedatives

Non-mental health related sleep disorders
Any other anxiety medications
Psychotherapy

The Anxiety and Related Sleep Disorders market in Morocco is experiencing steady growth due to increasing customer preferences for alternative therapies and rising awareness about mental health issues.

Customer preferences: Customers in Morocco are increasingly turning to alternative therapies for the treatment of anxiety and related sleep disorders. This is driven by a growing preference for natural and holistic approaches to healthcare. Traditional Moroccan practices such as herbal medicine, aromatherapy, and relaxation techniques are gaining popularity among individuals seeking relief from anxiety and sleep disorders. Additionally, there is a rising demand for non-pharmacological interventions such as cognitive behavioral therapy and mindfulness-based stress reduction.

Trends in the market: One of the key trends in the Anxiety and Related Sleep Disorders market in Morocco is the growing adoption of technology-based solutions. Mobile applications and online platforms that offer mental health support and guidance are becoming more prevalent. These platforms provide access to self-help resources, virtual therapy sessions, and community support, making it easier for individuals to seek help and manage their conditions.Another trend in the market is the increasing availability of over-the-counter (OTC) products for anxiety and sleep disorders. Moroccan consumers are seeking convenient and accessible solutions for their mental health concerns. OTC products such as herbal supplements and sleep aids are becoming more widely available in pharmacies and health food stores, catering to this demand.

Local special circumstances: Morocco has a unique cultural and social context that influences the development of the Anxiety and Related Sleep Disorders market. The country has a high prevalence of traditional healing practices, which are deeply rooted in Moroccan culture. This has contributed to the popularity of alternative therapies for anxiety and sleep disorders. Additionally, the stigma surrounding mental health issues is gradually diminishing, leading to increased acceptance and openness towards seeking treatment.

Underlying macroeconomic factors: The growing Anxiety and Related Sleep Disorders market in Morocco is also influenced by underlying macroeconomic factors. The country's economic development and rising disposable incomes have resulted in increased healthcare spending. This has allowed individuals to prioritize their mental health and seek appropriate treatment for anxiety and sleep disorders. Furthermore, the government's efforts to improve access to healthcare services and raise awareness about mental health have also contributed to the market's growth.In conclusion, the Anxiety and Related Sleep Disorders market in Morocco is witnessing growth due to shifting customer preferences towards alternative therapies, the adoption of technology-based solutions, and the availability of OTC products. The unique cultural context and increasing acceptance of mental health issues in the country, along with favorable macroeconomic factors, are driving the market's development.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.